Who Paid My Doc
Low Risk Bicuspid
Research payments
$4,764,702
Through program year 2025, $4,764,702 in research payments was reported against Low Risk Bicuspid, across 1,390 payments.
- Paid by (largest first)
- Medtronic Vascular, Inc.; Medtronic, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $175,577 | 168 |
| 2024 | Research | $486,045 | 173 |
| 2023 | Research | $343,798 | 192 |
| 2022 | Research | $475,965 | 188 |
| 2021 | Research | $561,077 | 210 |
| 2020 | Research | $858,580 | 234 |
| 2019 | Research | $1,863,659 | 225 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jae Oh Rochester, MN Named on 47 payments
- Jonathan Waks Boston, MA Named on 31 payments
- Megan Leary Allentown, PA Named on 28 payments
- John Crouch Milwaukee, WI Named on 27 payments
- William Merhi Grand Rapids, MI Named on 26 payments
- George Deeb Ann Arbor, MI Named on 24 payments
- Samin Sharma New York, NY Named on 24 payments
- Stanley Chetcuti Ann Arbor, MI Named on 23 payments
- David Adams New York, NY Named on 22 payments
- George Petrossian Greenvale, NY Named on 21 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.